세계의 인공장기 시장

Highlights:

The global artificial organs market should reach $17.7 billion by 2028 from $14.4 billion in 2023 at a compound annual growth rate (CAGR) of 4.2% for the forecast period of 2023 to 2028.

Artificial kidney segment of the global artificial organs market is expected to grow from $5.8 billion in 2023 to $6.8 billion in 2028 at a CAGR of 3.3% for the forecast period of 2023 to 2028.

Artificial heart segment of the global artificial organs market is expected to grow from $1.4 billion in 2023 to $1.9 billion in 2028 at a CAGR of 6.5% for the forecast period of 2023 to 2028.

Report Scope:

This report is a comprehensive study of the global artificial organs market. It describes the artificial organs market, segmented by product type and region. Based on product type, the market is segmented into artificial hearts, artificial kidneys, artificial lungs, artificial pancreases, and cochlear implants. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific, and the Rest of the World (RoW).

This report examines the factors driving growth in the artificial organ market, and it reviews major players, established companies, and new entrants.

This report, however, does not cover artificial limbs, artificial eyes, artificial intestines, artificial skin, or artificial blood vessels.

Report Includes:

• 28 data tables and 14 additional tables
• An overview of the global artificial organs market
• Analyses of global market trends, with data from 2020 to 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
• Discussion about the benefits of using artificial organs over traditional organs in transplantation surgeries, and increase in development of new types of artificial organs as driving factors to the market
• Identification of challenges and discussion on how to overcome from those to reach its commercialization potential
• Insights into R&D investments, government growth-promoting policies, rules, and regulations
• Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
• Detailed company profiles of major players in the market, including Abbott, Getinge AB, LivaNova, Nipro Corp. and Sonova

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• Methodology
• Information Sources
• Primary Research
• Secondary Research
• Geographic Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Highlights of the Artificial Organs Market

Chapter 3 Market Overview and Definitions

• Overview
• Artificial Organs

Chapter 4 Market Trends

• Market Drivers
• Aging Population
• Diabetic Cases by Countries
• Chronic Kidney Disease Cases by Countries
• Penetration of Artificial Organs in Emerging Markets
• Market Opportunity
• Market Restraints

Chapter 5 Market Breakdown by Product Type

• Introduction
• Artificial Heart
• Artificial Kidney
• Artificial Lung
• Artificial Pancreas
• Cochlear Implant

Chapter 6 COVID-19 Impact Analysis

• Introduction
• COVID-19 Impact on the Medical Devices and Pharmaceutical Industries
• Decline/Delay in Elective Procedures
• Impact of COVID-19 on Medical Device and Pharmaceutical Product Segments
• COVID-19 Impact on Artificial Organs Markets

Chapter 7 Market Breakdown by Region

• Market Overview and Discussion
• North America
• U.S.
• Canada
• Mexico
• Latin America
• Brazil
• Argentina
• Chile
• Europe
• Germany
• France
• U.K.
• Spain
• Italy
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World

Chapter 8 Competitive Landscape

• Industry Scenario
• Company Shares

Chapter 9 Emerging/Upcoming Technologies

• Key/Emerging Technologies/Trends in the Market
• Tissue Engineering and Regenerative Medicine
• Organ-on-a-Chip
• Bio-fabrication and 3D Bioprinting
• Biomaterials and Biocompatible Materials
• Immunomodulation and Immunotolerance Strategies
• Neural Interfaces and Brain-Machine Interfaces
• Gene Editing and Gene Therapy

Chapter 10 M&A and Fundings Outlook

• M&A Analysis
• SynCardia System's Acquisition by Versa Capital Management
• Abiomed's Acquisition of Berlin Heart
• LivaNova's Acquisition of TandemLife
• Fresenius Medical Care's Acquisition of NxStage Medical
• B. Braun's Acquisition of NxStage Medical's Bloodlines Business
• LivaNova's Acquisition of TandemLife
• Cantel Medical's Acquisition of hemodialysis business from Gambro
• Eli Lilly's Acquisition of Protomer Technologies
• Johnson & Johnson Acquisition of Abiomed Inc.

Chapter 11 Sustainability in Artificial Organs Market: An ESG Perspective

• Introduction
• Environmental Factors
• Social Factors
• Governance Factors
• Artificial Organs Market: ESG Performance Analysis, by Company
• Conclusion

Chapter 12 Patent Analysis

• Patent Analysis by Manufacturer

Chapter 13 Pipeline Analysis

• Clinical Trials Scenario

Chapter 14 Company Profiles

• ABIOMED
• ABBOTT
• BAXTER INTERNATIONAL INC.
• B. BRAUN SE
• COCHLEAR LTD.
• FRESENIUS MEDICAL CARE AG & CO. KGAA
• F. HOFFMANN-LA ROCHE AG
• GETINGE AB
• INSULET CORP.
• LIVANOVA PLC
• MEDTRONIC
• MED-EL MEDICAL ELECTRONICS
• NIPRO CORP.
• SONOVA
• TERUMO CORP.
• TANDEM DIABETES CARE, INC.
• YPSOMED AG